Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 7/2015

01-07-2015 | Erratum

Erratum to: A novel ELISA for diagnosis of Glanzmann’s thrombasthenia and the heterozygote carriers

Authors: Vivian Lobo, Shrimati Shetty, Bipin Kulkarni, Diego Butera, Geraldo S. Magalhaes, Kanjaksha Ghosh

Published in: Annals of Hematology | Issue 7/2015

Login to get access

Excerpt

Erratum to: Annals of Hematology 91(6): 917–921 …
Metadata
Title
Erratum to: A novel ELISA for diagnosis of Glanzmann’s thrombasthenia and the heterozygote carriers
Authors
Vivian Lobo
Shrimati Shetty
Bipin Kulkarni
Diego Butera
Geraldo S. Magalhaes
Kanjaksha Ghosh
Publication date
01-07-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 7/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-015-2382-3

Other articles of this Issue 7/2015

Annals of Hematology 7/2015 Go to the issue

Original Article

Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States

Letter to the Editor

Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab

Original Article

Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy

Original Article

The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia

Letter to the Editor

Erythropoietin receptor mutation—a rush of blood to the head?

Original Article

Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician’s and patient’s perspectives
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits